|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryptocurrency News Articles
Synthetix and Derive Cancel $27M Merger Proposal After Community Pushback
May 27, 2025 at 05:01 am
Plans for a $27 million merger between Synthetix and Derive (formerly Lyra) have been scrapped, as both teams announced they have mutually withdrawn their respective proposals

Plans for a $27 million merger between Synthetix and Derive (formerly Lyra) have been scrapped, as both teams announced they have mutually withdrawn their respective proposals following community feedback and internal discussions.
The proposed deal aimed to integrate Derive’s decentralized options platform with Synthetix’s derivatives ecosystem on Ethereum. It was formalized in Synthetix Improvement Proposal 415 (SIP-415) and Derive Improvement Proposal (DIP).
Under the terms, Synthetix would acquire Derrive’s treasury, technology, and product suite via a token swap.
The deal would have seen 29.3 million new SNX tokens minted, with a token swap ratio of 27 DRV to 1 SNX, effectively valuing Derive at $27 million.
Key Developments Poised to Influence the Crypto Market in the Next Days
Proposal Withdrawn After Community Discussion
On Friday, Derive confirmed the cancellation, stating:
“The SIP-415 and DIP proposals to merge Synthetix and Derive have been mutually withdrawn after thoughtful discussion and community feedback.”
The move follows a period of deliberation and feedback from members of both the Synthetix and Derive communities.
As previously reported by TokenInsight, the proposed merger sparked discussion among crypto users on social media, with some expressing skepticism about the deal terms and the broader integration of the two protocols.
The proposed deal aimed to integrate Derive’s decentralized options platform with Synthetix’s derivatives ecosystem on Ethereum. It was formalized in Synthetix Improvement Proposal 415 (SIP-415) and Derive Improvement Proposal (DIP).
The proposal would have seen Synthetix acquire Derive’s treasury, technology, and product suite via a token swap.
The deal would have also seen 29.3 million new SNX tokens minted, with a token swap ratio of 27 DRV to 1 SNX, which effectively values Derive at $27 million.
However, the proposed deal faced significant backlash from members of both the Synthetix and Derive communities, who raised concerns about the valuation of the two protocols, the governance implications of the merger, and the broader strategic direction of the combined entity.
Following this backlash, both teams announced they have mutually withdrawn their respective proposals after internal discussions and community feedback.
Both projects remain committed to improving the decentralized derivatives space.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































